Chiquita Confirms Receipt of Unsolicited Offer From Cutrale

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Chiquita Confirms Receipt of Unsolicited Offer From Cutrale Group and Safra Group

CHARLOTTE, N.C., Aug. 11, 2014 (GLOBE NEWSWIRE) -- Chiquita Brands International, Inc. (NYSE: CQB ), today confirmed that it has received an unsolicited offer from the Cutrale Group and the Safra Group to acquire all of the outstanding common stock of Chiquita at a price of $13.00 per share in cash to Chiquita shareholders.

Consistent with its fiduciary duties, Chiquita's Board of Directors, in consultation with its legal and financial advisors, will carefully review and consider the offer to determine the course of action that it believes is in the best interests of the Company and its shareholders. Chiquita shareholders are advised to take no action at this time and to await the Board's recommendation. Chiquita will have no further comment on the Cutrale Group and the Safra Group's offer until the Board has completed its review.

As previously announced on March 10, 2014, Chiquita entered into a definitive merger agreement with Fyffes plc (ESM: FFY ID: AIM: FFY LN), under which Chiquita would combine with Fyffes in a stock-for-stock transaction. On completion of the transaction, Chiquita shareholders will own approximately 50.7% of ChiquitaFyffes, and Fyffes shareholders owning approximately 49.3% of ChiquitaFyffes, on a fully diluted basis. The agreement creates a global banana and other fresh produce company with approximately $4.6 billion in annual revenues. We continue to strongly believe in the strategic merits and value provided by the proposed transaction with Fyffes plc.

Goldman Sachs is acting as lead financial adviser to Chiquita and Wells Fargo Securities, LLC is acting as financial adviser to the Chiquita Board of Directors. Skadden, Arps, Slate, Meagher & Flom LLP, McCann FitzGerald and Taft Stettinius & Hollister LLP are acting as legal counsel to Chiquita.

About Chiquita Brands International, Inc.

Chiquita Brands (NYSE: CQB ) is a leading international marketer and distributor of nutritious, high-quality fresh and value-added food products - from energy-rich bananas, blends of convenient green salads, other fruits to healthy snacking products. The company markets its healthy, fresh products under the Chiquita® and Fresh Express® premium brands and other related trademarks. With annual revenues of more than $3 billion, Chiquita employs approximately 20,000 people and has operations in approximately 70 countries worldwide. For more information, please visit www.chiquita.com .

Forward Looking Statements

This communication contains certain statements that are "forward-looking statements." These statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of Chiquita and Fyffes, including: the customary risks experienced by global food companies, such as prices for commodity and other inputs, currency exchange fluctuations, industry and competitive conditions (all of which may be more unpredictable in light of continuing uncertainty in the global economic environment), government regulations, food safety issues and product recalls affecting Chiquita and/or Fyffes or the industry, labor relations, taxes, political instability and terrorism; unusual weather events, conditions or crop risks; continued ability of Chiquita and Fyffes to access the capital and credit markets on commercially reasonable terms and comply with the terms of their debt instruments; access to and cost of financing; and the outcome of pending litigation and governmental investigations involving Chiquita and/or Fyffes, as well as the legal fees and other costs incurred in connection with these items. Readers are cautioned that any forward-looking statement is not a guarantee of future performance and that actual results could differ materially from those contained in the forward-looking statement. Forward-looking statements relating to the combination involving Fyffes and Chiquita include, but are not limited to: statements about the benefits of the combination, including expected synergies and future financial and operating results; Fyffes and Chiquita's plans, objectives, expectations and intentions; the expected timing of completion of the combination; and other statements relating to the combination that are not historical facts. Forward-looking statements involve estimates, expectations and projections and, as a result, are subject to risks and uncertainties. There can be no assurance that actual results will not materially differ from expectations. Important factors could cause actual results to differ materially from those indicated by such forward-looking statements.

With respect to the combination, these factors include, but are not limited to: risks and uncertainties relating to the ability to obtain the requisite Fyffes and Chiquita shareholder approvals; the risk that Fyffes or Chiquita may be unable to obtain governmental and regulatory approvals required for the combination, or required governmental and regulatory approvals may delay the combination or result in the imposition of conditions that could reduce the anticipated benefits from the combination or cause the parties to abandon the combination; the risk that a condition to closing of the combination may not be satisfied; the length of time necessary to consummate the combination; the risk that the businesses will not be integrated successfully; the risk that the cost savings and any other synergies from the combination may not be fully realized or may take longer to realize than expected; disruption arising as consequence of the combination making it more difficult to maintain existing relationships or establish new relationships with customers, employees or suppliers; the diversion of management time on transaction-related issues; the ability of the combined company to retain and hire key personnel; the effect of future regulatory or legislative actions on the companies; and the risk that the credit ratings of the combined company or its subsidiaries may be different from what the companies expect.

These risks, as well as other risks associated with the combination, are more fully discussed in the Proxy Statement/Prospectus/Scheme Circular that is included in the Registration Statement on Form S-4 that was filed with the SEC in connection with the combination and are contained in the definitive Proxy Statement/Prospectus/Scheme Circular being mailed to shareholders. Additional risks and uncertainties are identified and discussed in Chiquita's reports filed with the SEC and available at the SEC's website at www.sec.gov and in Fyffes reports filed with the Registrar of companies available at Fyffes website at www.fyffes.com . Forward-looking statements included in this document speak only as of the date of this document. Neither Chiquita nor Fyffes undertakes any obligation to update its forward-looking statements to reflect events or circumstances after the date of this communication.

No statement in this communication is intended to constitute a profit forecast for any period, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for Chiquita, or Fyffes or ChiquitaFyffes, as appropriate. No statement in this communication constitutes an asset valuation.

Statement Required by the Takeover Rules

The directors of Chiquita accept responsibility for the information contained in this communication. To the best of the knowledge and belief of the directors of Chiquita (who have taken all reasonable care to ensure that such is the case), the information contained in this communication for which they accept responsibility is in accordance with the facts and does not omit anything likely to affect the import of such information.

Chiquita Contacts: Investors Steve Himes 1 980-636-5636 Media Ed Loyd 1 980-636-5145 Kelly Sullivan, Averell Withers or Joseph Sala Joele Frank, Wilkinson Brimmer Katcher 1 212-355-4449

Scroll down for more posts ▼

Top 10 Most Recent News Articles

OUTFRONT Media Gears Up for Q3 2026 Earnings Reveal

Updated Category News Views 3

OUTFRONT Media’s Earnings Drumroll Heading toward that red-letter date of November 5, OUTFRONT Media (NYSE: OUT) has got its ducks in a row. They're ready to spill the beans on third-quarter numbers after close of market—just as clocks hit 4:30 p.m. Eastern. It’s showtime, folks. What’s at Stake? We're talking OUTFRONT Media—one of the big kahunas in out-of-home...

Continue Reading
WF Holding Cancels Additional Purchase Rights in Deal

Updated Category News Views 4

WF Holding Calls Off Extra Purchase Rights Well, someone's decided to hit the brakes over at WF Holding Limited (NASDAQ:WFF). They're pulling the plug on an extra purchase gravy train they’d previously left open for investors. Straight from Kuala Lumpur, WF Holding's been in the fiberglass plastic game for over three decades, pushing out a product line that's almost as...

Continue Reading
Pediatric Dental Visits: Setting the Stage Early Matters

Updated Category News Views 4

Unlocking the Secrets of First Dental Visits When should little ones start showing up in that dental chair? You might be thinking, "I'll wait until they actually have a full set of chompers," but that's a rookie move, folks. A piece coming out of HelloNation suggests parents hustle those kiddos into the dentist's office by their first birthday or six months after the...

Continue Reading
Savarese Joins RID to Drive Diagnostic Innovation

Updated Category News Views 3

A Seasoned Leader Bolsters RID's Ambitions Mario Savarese has joined Rapid Infection Diagnostics Inc.'s Strategic Advisory Board, and let me tell ya, this move's got potential. Appointing a heavyweight like Savarese as an advisor isn’t just a nod to his hefty resume. It’s about vaulting a burgeoning company into the big leagues. He's got over 20 years steering a ship...

Continue Reading
Guwahati Training Elevates Ophthalmologists: More Ready Surgeons

Updated Category News Views 4

Expanding Horizons: Training Where It's Needed The universe of cataract surgery in India saw an encouraging turn with HelpMeSee's recent initiative in Guwahati. This operation hit the sweet spot for Northeast India's ophthalmologists by bringing top-notch surgical training directly to their doorstep. Bye-bye long, costly trips to distant cities for training—this time,...

Continue Reading
3D Concrete Printing Set to Transform Construction by 2035

Updated Category News Views 3

Concrete Revolution: The 3D Printing Surge Times are changing in construction, and this ain’t your grandfather’s cinder block. We're talking about 3D concrete printing here—an industry poised to swell from just a pipedream sort of $293.4 million in 2025 to a staggering $1.87 billion by 2035. Driven by housing demands and resilient defense contracts, the sector is...

Continue Reading
Direct Digital's Bold Exit: Delists from Nasdaq

Updated Category News Views 3

Delisting Drama: Navigating Direct Digital's Market Move Looks like Direct Digital Holdings is getting caught up in the whirlwind of delisting and deregistering its Class A common stock from the Nasdaq. This move isn't just about hopping off a big exchange—it’s a whole new set of dance steps in the market. Timing and Mechanics of the Departure They’ve set their...

Continue Reading
Cognizant Buys DyFlex for SAP, AI Edge in ANZ

Updated Category News Views 0

Why Cognizant's Move Matters Imagine being at the top of your game, only to realize you need more heavy-hitters to keep your edge. That’s this deal in a nutshell. Cognizant (NASDAQ: CTSH) is diving deep into AI-led enterprise transformation by scooping up DyFlex Solutions, a name with plenty of clout in the SAP ecosystem. What's Behind the DyFlex Acquisition? Founded in...

Continue Reading
FFR Set to Unveil Strategy at Nasdaq Event in NYC

Updated Category News Views 12

An Exciting Day for FFR on Wall Street Hold onto your hats, investors! FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) is about to make a splash in the big leagues at its much-anticipated Nasdaq listing ceremony. Slated for October 26 at the iconic Nasdaq Tower in NYC, it's a day that could pivot the company’s future centerpiece strategy, jacking up anticipation like...

Continue Reading
Factors Driving Up Car Window Tinting Costs Explained

Updated Category News Views 2

Decoding the Dollars Behind Car Window Tinting When you think about car upgrades, window tinting might not scream excitement. But, my friends, it ain't all about the aesthetics. Dive into the nuts and bolts of cost with insights from Francis Alegre, a seasoned pro from StayShine Detailing in Voorhees, New Jersey, featured in HelloNation's rundown. The Glass Mass Factor...

Continue Reading

Top 5 Most Recently Viewed Articles

Definitive Healthcare Celebrated as a Top Boston Employer

Updated Category News Views 89

Definitive Healthcare Honored as a Premier Workplace Definitive Healthcare (NASDAQ: DH), a leading name in healthcare commercial intelligence, has recently earned prestigious recognition as one of the top employers in Boston. Celebrated by Built In’s 2025 Best Places to Work program, this accolade acknowledges businesses that foster exceptional workplace environments....

Continue Reading
Euroseas Q4 Earnings Beat Expectations: Key Insights

Updated Category News Views 157

Euroseas Earnings Report: Highlights and Performance The market loves a good surprise, and Euroseas just tossed a nice one into the mix with their latest earnings. Released February 25, 2026, at 08:00 AM, they’ve performed better than expected, snagging attention from investors ready for a ride. Earnings Overview Let’s cut to the chase: Euroseas reported an earnings...

Continue Reading
AstraZeneca and Daiichi Sankyo's Datroway: A Game Changer

Updated Category News Views 208

Introduction to Datroway's Impact on Breast Cancer Treatment AstraZeneca Plc (NASDAQ: AZN) and Daiichi Sankyo have announced remarkable findings from their TROPION-Breast02 Phase 3 trial for the drug Datroway (datopotamab deruxtecan), set to revolutionize the approach to treating triple-negative breast cancer (TNBC). This pharmaceutical collaboration showcases significant...

Continue Reading
Compute Exchange Revolutionizes AI Compute Market Dynamics

Updated Category News Views 806

Compute Exchange Revolutionizes AI Compute Market Dynamics Today marks a significant shift in the way AI compute resources are bought and sold with the introduction of Compute Exchange. This pioneering platform provides the first open exchange specifically designed for GPUs and various other compute resources, addressing the needs of both buyers and sellers in an...

Continue Reading
NuZee Stock Surges on Major Operational Changes and Leadership Shift

Updated Category News Views 88

NuZee Inc. Makes Headlines with Strategic Relocation NuZee, Inc. NUZE is witnessing a significant surge in its stock trading activity. The reason behind this movement is the recent announcement of the company relocating its U.S. operations from California to Florida. This strategic decision aims to bolster its operational efficiency and accessibility. Global Expansion...

Continue Reading